SenesTech, Inc. (SNES) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. SenesTech, Inc. is a biotechnology company developing and commercializing fertility control products for pest management, primarily targeting rat and mouse populations. Key products include ContraPest (liquid bait), Evolve (soft bait launched Jan 2024), and Evolve Mouse (launched May 2024). The company is classified as a smaller reporting company and a non-accelerated filer.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Revenue | $459,000 | $305,000 | $874,000 | $538,000 |
| Gross Profit | $249,000 | $142,000 | $384,000 | $234,000 |
| Gross Margin | 54.2% | 46.4% | 43.9% | 43.5% |
| Net Loss | $(1,584,000) | $(1,993,000) | $(3,416,000) | $(4,030,000) |
| Cash & Equivalents (End of Period) | $1,952,000 | $2,196,000 | $1,952,000 | $2,196,000 |
| Accumulated Deficit | $(133.3M) | $(126.2M) | $(133.3M) | $(126.2M) |
| Total Debt (Notes Payable) | $201,000 | N/A | $201,000 | N/A |
Note: Financial data is presented in thousands unless otherwise noted. Debt consists of equipment financing notes with a weighted average interest rate of 8.9%.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 50% in Q2 2024 compared to Q2 2023, driven primarily by the launch of the "Evolve" product line, which accounted for approximately 58% of Q2 revenue. This growth partially offset a decline in units sold of the legacy "Elevate Bait System."
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased 21% in Q2 2024 compared to the prior year, largely due to lower personnel costs (reduced headcount and stock-based compensation) and lower professional fees following a legal settlement in late 2023.
- Improved Margins: Gross margin improved to 54.2% in Q2 2024 from 46.4% in Q2 2023, attributed to a favorable shift in product mix toward the higher-margin Evolve products.
- Cash Burn: Net cash used in operating activities was $3.4 million for the six months ended June 30, 2024, compared to $3.8 million in the prior year period. Cash balances decreased from $5.4 million at year-end 2023 to $2.0 million at June 30, 2024.
Guidance, Outlook, and Risks
- Liquidity and Going Concern: Management states that current cash ($2.0 million) combined with anticipated revenue is sufficient to fund operations for at least the next three months. The company explicitly notes it will require additional financing to achieve revenue targets and fund ongoing R&D. There is substantial doubt about the company's ability to continue as a going concern without additional capital.
- Capital Needs: The company expects to continue incurring significant operating losses for the foreseeable future. It has established an "At-The-Market" (ATM) facility to sell up to $1.58 million of common stock, though no shares had been sold under this facility as of June 30, 2024.
- Subsequent Events: On July 23, 2024, the company effected a 1-for-10 reverse stock split. Financial statements in this filing have been retrospectively adjusted to reflect this split.
- Risks: Key risks include the inability to raise necessary capital, delays in commercialization, regulatory approval challenges, and dependence on a limited number of distributors (one distributor accounted for 14% of Q2 revenue).
Investor Verification Checklist
- Cash Runway: Verify the timeline for the next capital raise given the $2.0 million cash balance and ~$1.6M quarterly burn rate.
- Product Mix Sustainability: Confirm if the high gross margins from the new "Evolve" product line are sustainable as raw material costs stabilize from development to production pricing.
- Reverse Stock Split Impact: Assess the impact of the 1-for-10 reverse split on share liquidity and Nasdaq listing compliance.
- Distributor Concentration: Monitor the reliance on specific distributors, as one distributor represented 32% of accounts receivable as of June 30, 2024.
- ATM Facility Utilization: Track whether the company successfully utilizes the $1.58 million ATM facility to extend its operating runway.